Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
{ "Transcranial Direct Current Stimulation for Parkinson's Disease Motor Function and Fatigue", "This study is exploring if transcranial direct current stimulation (tDCS) can help improve motor function (movement) and reduce fatigue in people with Parkinson's Disease (PD). Researchers believe that tDCS, a non-invasive brain stimulation technique, might lead to lasting improvements. You might be able to join if you have a clinical diagnosis of PD with at least two of the four main symptoms (tremor, rigidity, slow movement, or balance issues) and can give consent. People with dementia, deep brain stimulation (DBS), psychosis, multiple sclerosis, or stroke cannot participate. The study will measure success by looking at finger and toe-tapping ability using a device called KinesiaOne. The current status of this study is unclear, and it plans to enroll 64 participants.", "design": "This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 64 participants to test transcranial direct current stimulation (tDCS) against a sham (no treatment) device.", "commitments": "Participants will receive either tDCS or a sham treatment for 20 minutes a day for 5 consecutive days. There will be multiple research visits, including pre-treatment, post-treatment, and follow-up tests.", "compensation": "Not stated in the trial record.", "follow_up": "Participants will have follow-up tests 7 days and 14 days after their last tDCS session.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
At a glance
Conditions
NCT06883266
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Sanford Brain and Spine Center
Fargo, North Dakotastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Jau-Shin Lou, MD · PRINCIPAL_INVESTIGATOR · Sanford Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Finger and Toe-Tapping on KinesiaOne Device30 minutes; pre-test during the second research visit, post-test on 6th research visit after 5 consecutive days of tDCS, a follow up test on the 7th research visit, 7 days after last tDCS session and 8th visit 14 days after last tDCS session
We will use the KinesiaOne measure the finger tapping and foot tapping for 15 seconds. It will repeat 3 times at 1 minute intervals. KinesiaOne is a light-weight device that can be attached to the Index finger or ankle. It measures the acceleration and deceleration of the finger or foot. The measurement is transmitted to the KinesiaOne tablet that allows further data processing.